133 related articles for article (PubMed ID: 38365182)
1. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Caon E; Martins M; Hodgetts H; Blanken L; Vilia MG; Levi A; Thanapirom K; Al-Akkad W; Abu-Hanna J; Baselli G; Hall AR; Luong TV; Taanman JW; Vacca M; Valenti L; Romeo S; Mazza G; Pinzani M; Rombouts K
J Hepatol; 2024 Jun; 80(6):941-956. PubMed ID: 38365182
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells.
Bruschi FV; Tardelli M; Einwallner E; Claudel T; Trauner M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218077
[TBL] [Abstract][Full Text] [Related]
3. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
Bruschi FV; Claudel T; Tardelli M; Caligiuri A; Stulnig TM; Marra F; Trauner M
Hepatology; 2017 Jun; 65(6):1875-1890. PubMed ID: 28073161
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.
Pingitore P; Dongiovanni P; Motta BM; Meroni M; Lepore SM; Mancina RM; Pelusi S; Russo C; Caddeo A; Rossi G; Montalcini T; Pujia A; Wiklund O; Valenti L; Romeo S
Hum Mol Genet; 2016 Dec; 25(23):5212-5222. PubMed ID: 27742777
[TBL] [Abstract][Full Text] [Related]
5. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A
PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
7. AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.
Tardelli M; Bruschi FV; Claudel T; Moreno-Viedma V; Halilbasic E; Marra F; Herac M; Stulnig TM; Trauner M
Sci Rep; 2017 Nov; 7(1):14661. PubMed ID: 29116096
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.
Banini BA; Kumar DP; Cazanave S; Seneshaw M; Mirshahi F; Santhekadur PK; Wang L; Guan HP; Oseini AM; Alonso C; Bedossa P; Koduru SV; Min HK; Sanyal AJ
Hepatology; 2021 Apr; 73(4):1290-1306. PubMed ID: 33131062
[TBL] [Abstract][Full Text] [Related]
9.
Bruschi FV; Claudel T; Tardelli M; Starlinger P; Marra F; Trauner M
Hepatol Commun; 2019 Sep; 3(9):1191-1204. PubMed ID: 31497741
[TBL] [Abstract][Full Text] [Related]
10. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH.
Bruschi FV; Tardelli M; Herac M; Claudel T; Trauner M
Liver Int; 2020 May; 40(5):1098-1110. PubMed ID: 32043752
[TBL] [Abstract][Full Text] [Related]
11. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.
Pirazzi C; Valenti L; Motta BM; Pingitore P; Hedfalk K; Mancina RM; Burza MA; Indiveri C; Ferro Y; Montalcini T; Maglio C; Dongiovanni P; Fargion S; Rametta R; Pujia A; Andersson L; Ghosal S; Levin M; Wiklund O; Iacovino M; Borén J; Romeo S
Hum Mol Genet; 2014 Aug; 23(15):4077-85. PubMed ID: 24670599
[TBL] [Abstract][Full Text] [Related]
12. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
[TBL] [Abstract][Full Text] [Related]
13. IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease.
Park J; Zhao Y; Zhang F; Zhang S; Kwong AC; Zhang Y; Hoffmann HH; Bushweller L; Wu X; Ashbrook AW; Stefanovic B; Chen S; Branch AD; Mason CE; Jung JU; Rice CM; Wu X
J Hepatol; 2023 Jan; 78(1):45-56. PubMed ID: 36049612
[TBL] [Abstract][Full Text] [Related]
14. Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
Su H; Haque M; Becker S; Edlund K; Duda J; Wang Q; Reißing J; Marschall HU; Candels LS; Mohamed M; Sjöland W; Liao L; Drexler SA; Strowig T; Rahnenführer J; Hengstler JG; Hatting M; Trautwein C
Liver Int; 2023 Aug; 43(8):1699-1713. PubMed ID: 37073116
[TBL] [Abstract][Full Text] [Related]
15. CAT1 silencing inhibits TGF-β1-induced mouse hepatic stellate cell activation in vitro and hepatic fibrosis in vivo.
Peng F; Tian Y; Ma J; Xu Z; Wang S; Tang M; Lei J; Gong G; Jiang Y
Cytokine; 2020 Dec; 136():155288. PubMed ID: 32980687
[TBL] [Abstract][Full Text] [Related]
16. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
Kovarova M; Königsrainer I; Königsrainer A; Machicao F; Häring HU; Schleicher E; Peter A
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1568-74. PubMed ID: 26439088
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.
Carson JP; Robinson MW; Ramm GA; Gobert GN
Mol Biol Rep; 2021 Dec; 48(12):7677-7688. PubMed ID: 34648138
[TBL] [Abstract][Full Text] [Related]
18. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
[TBL] [Abstract][Full Text] [Related]
20. MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis.
Pydyn N; Ferenc A; Trzos K; Pospiech E; Wilamowski M; Mucha O; Major P; Kadluczka J; Rodrigues PM; Banales JM; Herranz JM; Avila MA; Hutsch T; Malczak P; Radkowiak D; Budzynski A; Jura J; Kotlinowski J
Cell Mol Gastroenterol Hepatol; 2024; 17(6):887-906. PubMed ID: 38311169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
